tiprankstipranks
Takeda Pharmaceutical Co Ltd (JP:4502)
TSE/TYO:4502
Holding JP:4502?
Track your performance easily

Takeda Pharmaceutical Co (4502) Ownership - Who Owns Takeda Pharmaceutical Co?

3 Followers

Takeda Pharmaceutical Co (4502) Ownership Overview

7.55%<0.01%8.66%83.79%
<0.01% Other Institutional Investors
8.66% ETFs
83.79% Public Companies and
Individual Investors
The ownership structure of Takeda Pharmaceutical Co (JP:4502) stock is a mix of institutional, retail, and individual investors. Approximately 16.21% of the company’s stock is owned by Institutional Investors, and 83.79% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 24, 2024
Giles Richard Platford
Divisional President
xxxxxxxxxxxxx
$284936
Jul 11, 2024
Giles Richard Platford
Divisional President
xxxxxxxxxxxxx
$273090
Jul 11, 2024
Thomas Wozniewski
Supply Chain Director
xxxxxxxxxxxxx
$59732
Jul 11, 2024
Marcello Pignagnoli Agosti
Business Development Officer
xxxxxxxxxxxxx
$140683

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
53,257,825Institution3.35%1,436,523,314
26,887,388Institution1.69%725,233,517
21,303,063Institution1.34%574,607,518
16,701,291Institution1.05%450,483,922
12,897,732Institution0.81%347,890,525
10,676,700Institution0.67%287,982,629
9,887,427Institution0.62%266,693,568
7,643,816Institution0.48%206,176,649
6,200,328Institution0.39%167,241,447
5,965,021Institution0.37%160,894,511

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
21,303,063Institution1.34%574,607,518
16,701,291Institution1.05%450,483,922
12,897,732Institution0.81%347,890,525
7,643,816Institution0.48%206,176,649
5,786,118Institution0.36%156,068,961
5,375,395Institution0.34%144,990,529
5,225,112Institution0.33%140,936,946
4,605,500Institution0.29%124,224,152
4,321,950Institution0.27%116,575,957
4,215,900Institution0.26%113,715,471

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,723,213Institution0.11%7,346,057,019
1,723,213Institution0.11%7,346,057,019
1,723,213Institution0.11%7,346,057,019
1,723,213Institution0.11%7,346,057,019
1,723,213Institution0.11%7,346,057,019
1,619,397Institution0.10%6,785,273,430
1,619,397Institution0.10%6,785,273,430
1,195,341Institution0.08%5,040,752,997
1,195,341Institution0.08%5,040,752,997
1,195,341Institution0.08%5,040,752,997

FAQ

Who Owns Takeda Pharmaceutical Co Ltd (JP:4502)?
Currently, no data Available
What percentage of Takeda Pharmaceutical Co Ltd (JP:4502) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of Takeda Pharmaceutical Co Ltd (JP:4502) stock is held by institutional investors.
    What percentage of Takeda Pharmaceutical Co Ltd (JP:4502) stock is held by retail investors?
    According to the latest TipRanks data, approximately 83.79% of Takeda Pharmaceutical Co Ltd (JP:4502) stock is held by retail investors.
      Who owns the most shares of Takeda Pharmaceutical Co Ltd (JP:4502)?
      iShares owns the most shares of Takeda Pharmaceutical Co Ltd (JP:4502).
        What is the significance of the ownership structure for a publicly traded company?
        The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis